APG Asset Management’s BioNTech BNTX Stock Holding History

APG Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.32M	Buy	77,686 +24,260	+45%	+$2.28M	0.02%	448
2026 Q1	$4.12M	Buy	53,426 +5,640	+12%	+$580K	0.01%	457
2025 Q4	$3.87M	Sell	47,786 -6,914	-13%	-$697K	0.01%	478
2025 Q3	$4.59M	Buy	54,700 +1,600	+3%	+$171K	0.01%	453
2025 Q2	$4.82M	Buy	53,100 +3,500	+7%	+$354K	0.01%	458
2025 Q1	$4.18M	Buy	49,600 +2,700	+6%	+$302K	0.01%	470
2024 Q4	$5.16M	Buy	+46,900	New	+$5.35M	0.01%	459

Other funds holding BNTX

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

DCP

Davern Capital Partners Ny, New York $587M AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

APG Asset Management's BNTX Position: Q2 2026 in Review

APG Asset Management increased its BioNTech (BNTX) stake by 45% in Q2 2026, buying an estimated $2.28M and bringing the position to 77,686 shares worth $6.32M. The position accounts for 0.02% of the portfolio, ranked #448.

APG Asset Management first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. 199 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

APG Asset Management held 77,686 shares of BioNTech worth $6.32M as of Q2 2026.
APG Asset Management bought 24,260 BioNTech shares in Q2 2026, an estimated $2.28M.
BioNTech made up 0.02% of APG Asset Management's portfolio in Q2 2026, its #448 holding.
APG Asset Management first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
199 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.